Attached files
| file | filename |
|---|---|
| 10-Q - 10-Q - Wave Life Sciences Ltd. | d179788d10q.htm |
| EX-31.1 - EX-31.1 - Wave Life Sciences Ltd. | d179788dex311.htm |
| EX-31.2 - EX-31.2 - Wave Life Sciences Ltd. | d179788dex312.htm |
| EX-32.1 - EX-32.1 - Wave Life Sciences Ltd. | d179788dex321.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of WAVE Life Sciences Ltd. (the “Company”) on Form 10-Q for the period ended March 31, 2016, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Kyle Moran, Vice President, Head of Finance of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
| (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
May 16, 2016
| By: | /s/ Kyle Moran | |
| Kyle Moran | ||
| Vice President, Head of Finance (Principal | ||
| Financial Officer and Principal Accounting Officer) |
This certification accompanies the Quarterly Report on Form 10-Q to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of WAVE Life Sciences Ltd. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of such Form 10-Q), irrespective of any general incorporation language contained in such filing.